AI assistant
Rua Bioscience Limited — Capital/Financing Update 2025
Dec 15, 2025
66262_rns_2025-12-16_7fe99cbe-7b1c-47e0-a134-41809fab95d5.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [113 x 58] intentionally omitted <==
Corporate Action Notice
Section 1: Issuer information (mandatory)
| Section 1: Issuer information (mandatory) | Section 1: Issuer information (mandatory) | Section 1: Issuer information (mandatory) | Section 1: Issuer information (mandatory) | Section 1: Issuer information (mandatory) | Section 1: Issuer information (mandatory) |
|---|---|---|---|---|---|
| Name of issuer | Rua Bioscience Limited | ||||
| Class of Financial Product | Ordinary shares | ||||
| NZX ticker code | RUA | ||||
| ISIN (If unknown, check on NZX website) |
NZRUAE0004S1 | ||||
| Name of Registry | Computershare Investor Services Limited | ||||
| Type of corporate action (Please mark with an X in the relevant box/es) |
Share Purchase Plan/retail offer |
Renounceable Rights issue or Accelerated Offer |
|||
| Capital reconstruction |
Non- Renounceable Rights issue or Accelerated Offer |
||||
| Call | Bonus issue | ||||
| Placement | X | ||||
| Record date | NA | ||||
| Ex Date (one business day before the Record Date) |
NA | ||||
| Currency | NZD | ||||
| External approvals required before offer can proceed on an unconditional basis? |
No | ||||
| Details of approvals required | NA | ||||
| Section 7: Placement (delete full section if not applicable, or mark ro |
ws as N/A if not applicable)* | ||||
| Number of Equity Securities to be issued |
11,280,843 | ||||
| Issue price per Equity Security | $0.025 | ||||
| Maximum dollar amount of Equity Securities to be issued1 |
$282,021.08 | ||||
| Proposed issue date | Thursday, 18 December 2025 |
1 Where the issue price per Equity Security is not fixed, and the number of Equity Securities to be issued is not known, the Issuer should instead indicate the maximum dollar amount of Equity Securities to be issued.
Page 1 of 3
| Existing holders eligible to participate2 |
Y (limited) |
|---|---|
| Related Parties eligible to participate3 |
N |
| Basis upon which participation by existing Equity Security holders will be determined |
Those existing eligible shareholders who applied for oversubscriptions in relation to Rua’s 1 for 3 rights offer announced 3 November 2025. |
| Purpose(s) for which the Issuer is issuing the Equity Securities |
To fund short-term and immediate business operating funding requirements. |
| Reason for placement rather than a pro-rata rights issue or an offer under a Share Purchase Plan in which the Issuer’s existing Equity Security holders would have been eligible to participate |
Having offered all shareholders the opportunity to participate in the rights offer, the placement shares represent oversubscriptions in excess of the rights offer amount. |
| Equity Securities to be issued subject to voluntary escrow |
Nil |
| Number and class of Equity Securities to be issued that will be subject to voluntary escrow and the date from which they will cease to be escrowed |
NA |
| Section 8: Lead Manager and Underwriter (mandatory) | |
| Lead Manager(s) appointed | N |
| Name of Lead Manager(s) | NA |
| Fees, commission or other consideration payable to Lead Manager(s) for acting as lead manager(s) |
Nil |
| Underwritten | N |
| Name of Underwriter(s) | NA |
| Extent of underwriting (i.e. amount or proportion of the offer that is underwritten) |
NA |
| Fees, commission or other consideration payable to Underwriter(s) for acting as underwriter(s) |
NA |
2 Issuers should answer Y if existing shareholders are eligible to participate even if their participation is subject to satisfaction of eligibility criteria applying to the placement generally, such as the offer only being made to investors in certain jurisdictions or with a certain status, such as wholesale, sophisticated or professional investors only.
3 Issuers should answer Y if there are no restrictions on participation by Related Parties as a result of their status as Related Parties (i.e. restrictions on participation applying to the placement generally should be disregarded).
2 of 3
| Summary of significant events that could lead to the underwriting being terminated |
NA | NA |
|---|---|---|
| Section 9: Authority for this announcement (mandatory) | ||
| Name of person authorised to make this announcement |
Paul Naske | |
| Contact person for this announcement | Paul Naske | |
| Contact phone number | 021 445 154 | |
| Contact email address | [email protected] | |
| Date of release through MAP | 16/12/2025 |
3 of 3